• Latest Posts

With $700 million Q3 rise, U.K. biotech spearheads European recovery

In Depth 16 Nov 2023

Meet the ‘biotech mafia’: how specialized biotech VC firms are dominating industry funding once again

In Depth 2 Oct 2023

PIPEs in biotech fundraising: is this growing trend fueled by economic uncertainty here to stay?

In Depth 11 Sep 2023

Evolving biotech funding trends: VCs lead new series B deals, but early-stage deals require insider support

BioGeneration Ventures closes BGV Fund V at €150M 

In Depth 13 Jul 2023

Gold rush over: what happens to biotech now that venture capital is out of reach?

New venture capital company Biovance Capital Partners launches

BIO International Convention 2023: The Highlights